WebJan 21, 2024 · WALTHAM, Mass., Jan. 20, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing … WebDyne has a broad portfolio of programs for serious muscle diseases, including candidates for myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit and follow us on Twitter, LinkedIn and Facebook. Role Summary:
Senior Director, Clinical Quality Assurance Job in Waltham, MA - Dyne …
WebJan 13, 2024 · Dyne Therapeutics announces the appointment of Molly White as Vice President, Medical Communications and Advocacy. ... (FSHD). Dyne was founded in 2024 and is based in Waltham, Mass. For more ... WebDyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue seen … opti free eye solution
Dyne Therapeutics: Contact Details and Business Profile
WebDec 11, 2024 · Dyne (Nasdaq: DYN) has leased 68,187 square feet at 1560 Trapelo Road in Waltham, where it plans to relocate next year. The company, which went public earlier this year, currently occupies 15,000 ... WebThis role is based in Waltham, MA without the possibility of being a remote role. This role will be for a 6 month period beginning in July 2024 ... Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual ... WebMay 20, 2024 · WALTHAM, Mass. – Dyne Therapeutics, a biotechnology company pioneering life-transforming therapies for patients with serious muscle diseases, today announced the acceleration of its programs in … porthgain brickworks